EPAM Systems
EPAM
$123.51
-0.08%
EPAM Systems is a global IT services and consulting firm specializing in platform engineering, software development, and digital transformation for enterprise clients, operating primarily in the Information Technology Services industry. The company is a premium, high-touch engineering partner rather than a low-cost outsourcing provider, with roughly 60% of revenue derived from North America and a delivery footprint that has been deliberately diversified away from its historical Ukraine, Belarus, and Russia engineering bases. The current investor narrative is dominated by a severe growth scare: weak 2026 organic growth guidance issued in February 2026 triggered a roughly 16% single-week drawdown, with investors debating whether generative AI is cannibalizing traditional software development and testing work. That debate is compounded by a sharp compression in GAAP profitability and a stock that has lost roughly a quarter of its value over the past year even as the broader technology market rallied, making EPAM a contested AI-disruption-versus-AI-beneficiary story.…
EPAM
EPAM Systems
$123.51
Related headlines
Investment Opinion: Should I buy EPAM Today?
Rating: Hold. The core thesis is that EPAM's extreme valuation compression (8.39x forward P/E, 2.10x sales) already discounts a severe AI-driven disruption, but the lack of near-term catalysts and recent analyst downgrades limit upside until organic growth and margins stabilize. The analyst consensus is 'buy' with a mean of 2.21 and an average target price of $122.82, implying just +4.2% upside from the current $117.91, suggesting limited near-term return potential.
Supporting evidence: The stock trades at 2.10x sales and 8.39x forward earnings, roughly a 40-50% discount to typical IT services peers on sales and a 60%+ discount on forward earnings. Revenue growth has decelerated to 7.56% YoY, but the balance sheet is exceptionally strong with debt-to-equity of 0.039 and cash per share of $19.28 (16% of market cap). Profitability remains solid in absolute terms with Q1 2026 net income of $82.5 million and TTM free cash flow of $543.6 million, though gross margin has compressed to 25.59%. The implied upside to the average analyst target is only 4.2%, but the high target of $200 implies 70% upside if growth recovers.
Risks and conditions: The biggest risks are continued margin compression (gross margin down 900 basis points over six quarters), negative free cash flow in Q1 2026 (-$54.2 million), and the unresolved AI disruption threat. This Hold would upgrade to Buy if Q2 2026 revenue grows sequentially and gross margin stabilizes above 26%, or if the stock breaks above $125 on strong volume. It would downgrade to Sell if revenue declines sequentially again or if gross margin falls below 25%. Valuation verdict: The stock appears undervalued relative to its own history (PS of 2.10x vs. 14.84x in Q4 2023) but fairly valued given the deteriorating fundamentals and uncertain growth outlook.
Sign up to view all
EPAM 12-Month Price Forecast
EPAM presents a classic deep-value versus deteriorating-fundamentals debate. The stock's 8.39x forward P/E and 2.10x sales are historically cheap, but the 900 basis point gross margin compression and negative Q1 2026 free cash flow suggest the market is correctly pricing in real business challenges. The recent 17.57% one-month rally and positive relative strength indicate short-term momentum has turned, but the 6-month change of -14.02% and YTD decline of 41.18% show the recovery is nascent. I would upgrade to bullish if Q2 2026 shows sequential revenue growth and gross margin stabilization above 26%, and downgrade to bearish if revenue declines again or gross margin falls below 25%. The risk/reward is balanced at current levels, favoring a neutral stance until clearer evidence emerges.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on EPAM Systems's 12-month outlook, with a consensus price target around $122.82 and implied upside of -0.6% versus the current price.
Average Target
$122.82
0 analysts
Implied Upside
-0.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$94 - $200
Analyst target range
Coverage is solid with 17 analysts, and the consensus recommendation is "buy" with a recommendation mean of 2.21 (where lower is more bullish). The average target price is $122.82, which implies roughly +4.2% upside from the current price of $117.91 — a modest but positive expected return. The distribution of recent institutional ratings is mixed-to-constructive: Wells Fargo maintains Overweight, TD Cowen maintains Buy, Guggenheim and Needham maintain Buy, while Morgan Stanley and Citigroup sit at Equal Weight/Neutral and Truist at Hold. Notably, the trend in ratings has been downward — Jefferies downgraded from Buy to Hold on May 29, 2026, and Goldman Sachs downgraded from Buy to Neutral on May 8, 2026, both following the weak guidance. The consensus leans cautiously bullish, but the recent downgrades and the modest implied upside suggest analysts see limited near-term catalysts. The target range is extremely wide, from a low of $94.00 to a high of $200.00 — a spread of $106, or roughly 90% of the current stock price. The high target of $200 assumes a full recovery in growth and multiple expansion back toward historical norms, likely predicated on AI-related engineering demand inflecting and margins stabilizing; it implies roughly +70% upside. The low target of $94.00 implies roughly -20% downside and prices in continued margin compression, further AI-driven cannibalization of traditional services, and a prolonged IT spending downturn. This unusually wide spread signals very low analyst conviction and high uncertainty about the company's trajectory — a classic setup for elevated volatility. The estimated EPS average of $15.17 and estimated revenue average of $6.14 billion for the forward period suggest analysts expect a meaningful earnings recovery, but the dispersion around those estimates (EPS range of $14.16-$16.21) is relatively tight, indicating the disagreement is more about the multiple than the earnings. Investors should treat the consensus target as a weak signal given the wide range and the recent downgrade pattern.
Drowning in data?
Find the real signal!
Bulls vs Bears: EPAM Investment Factors
The bear case currently has stronger near-term evidence: revenue growth has flatlined sequentially, gross margins have compressed 900 basis points over six quarters, and Q1 2026 free cash flow turned negative. However, the bull case rests on an extreme valuation disconnect—8.39x forward earnings and 2.10x sales versus historical multiples of 14.84x and 43.99x, respectively—which suggests the market has already priced in a severe AI-driven disruption. The single most important tension is whether EPAM can stabilize organic growth and margins by monetizing AI-related engineering work before the traditional services cannibalization accelerates. If Q2 2026 results show sequential revenue growth and gross margin stabilization above 26%, the re-rating potential is substantial; if not, the stock could retest its 52-week low of $73.06.
Bullish
- Extreme valuation compression: EPAM trades at just 2.10x sales and 8.39x forward earnings, versus historical PS ratios of 14.84x in Q4 2023 and 10.64x in Q4 2024. The forward P/E of 8.39x is roughly a 60% discount to typical IT services peers trading at 20-30x earnings, implying the market has already priced in severe AI disruption.
- Fortress balance sheet with net cash: Debt-to-equity is only 0.039 and the current ratio is 2.59, with cash per share of $19.28 representing about 16% of the $117.91 stock price. This net cash position provides ample liquidity to fund operations and buybacks even during a downturn.
- Momentum reversal underway: The stock is up 17.57% over the past month and 23.62% over three months, versus the S&P 500's -1.06% and +3.04%, generating relative strength of +18.63 and +20.58 percentage points. This sharp divergence from the longer-term downtrend suggests aggressive mean-reversion buying and potential short-covering given the 4.73 short ratio.
- Analyst consensus still bullish: 17 analysts cover EPAM with a consensus recommendation of 'buy' (mean 2.21) and an average target price of $122.82, implying +4.2% upside. The high target of $200 implies +70% upside if growth stabilizes and multiples re-rate toward historical norms.
Bearish
- Growth has flatlined sequentially: Q1 2026 revenue of $1.400 billion was up 7.56% YoY but declined sequentially from $1.408 billion in Q4 2025. The sequential stall of roughly $7.5 million is the real story, and weak 2026 organic growth guidance triggered a 16% single-week drawdown in February 2026.
- Severe margin compression: Gross margin has deteriorated from 34.56% in Q3 2024 to 25.59% in Q1 2026, a roughly 900 basis point compression over six quarters. Net margin fell to 6.92% in Q1 2026 from 11.68% in Q3 2024, reflecting pricing pressure, wage inflation, and an unfavorable revenue mix.
- Negative free cash flow in Q1: Q1 2026 free cash flow was negative $54.2 million with operating cash flow of negative $36.4 million, driven by a $229.6 million working capital drain. Free cash flow per share swung from +$4.88 in Q4 2025 to -$1.01 in Q1 2026, a yellow flag for cash conversion.
- AI disruption threat unresolved: The investment case hinges on whether AI-related engineering work can offset cannibalization of traditional development and testing engagements. Financial Services ($350.2M) and Consumer Goods/Retail ($273.9M) are the largest verticals and both are under AI-driven budget scrutiny, creating a structural growth headwind.
EPAM Technical Analysis
EPAM is in a damaged but recovering trend. The stock is down 25.30% over the past year and down 41.18% year-to-date, a stark underperformance versus the S&P 500's +16.22% 1-year and +12.08% YTD returns. At $117.91, the shares sit at roughly 30.1% of the 52-week range (52-week low of $73.06, high of $222.53), meaning they are trading in the lower third of the annual band — closer to capitulation territory than to momentum leadership, though the recent bounce suggests the worst of the selling may be behind it. The maximum drawdown of -65.65% confirms this was a violent de-rating, not a garden-variety pullback. Recent momentum has turned sharply positive and is diverging from the longer-term downtrend. The stock is up 17.57% over the past month and 23.62% over three months, versus the S&P 500's -1.06% and +3.04% over the same windows, producing relative strength of +18.63 and +20.58 percentage points, respectively. That is a genuine momentum reversal — the 1-month gain of 17.57% against a 1-year decline of 25.30% signals aggressive mean-reversion buying into an oversold name, likely short-covering as well given the 4.73 short ratio. The 6-month change of -14.02% and YTD change of -41.18% show the recovery is still early and has not yet repaired the intermediate-term damage. Key levels are well defined. Support rests at the 52-week low of $73.06, with the June 2026 capitulation low of $76.04 as the immediate floor; a breakdown below that zone would signal a fresh leg lower and validate the AI-disruption bear case. Resistance sits at the 52-week high of $222.53, but the more actionable near-term resistance is the $120-$125 area where the stock stalled in early September after rallying from $76 to $119.88. A decisive breakout above $125 would confirm the bottoming pattern; failure here risks a retest of the $95-$100 shelf. With a beta of 1.383, EPAM is roughly 38% more volatile than the market, which means position sizing should be materially smaller than a market-weight allocation and stops should be wider to avoid noise-driven exits.
Beta
1.38
1.38x market volatility
Max Drawdown
-65.7%
Largest decline past year
52-Week Range
$73-$223
Price range past year
Annual Return
-20.1%
Cumulative gain past year
| Period | EPAM Return | S&P 500 |
|---|---|---|
| 1m | +22.9% | -2.4% |
| 3m | +40.8% | +2.2% |
| 6m | -9.0% | +14.8% |
| 1y | -20.1% | +14.6% |
| ytd | -38.4% | +11.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EPAM Fundamental Analysis
Revenue growth has decelerated to a low-single-digit pace. Q1 2026 revenue was $1.400 billion, up 7.56% year-over-year, but the sequential trend is essentially flat: Q4 2025 was $1.408 billion, Q3 2025 was $1.394 billion, and Q2 2025 was $1.353 billion. The year-over-year comparison is flattered by a weak Q1 2025 base of $1.302 billion, and the sequential stall from Q4 to Q1 (a decline of roughly $7.5 million) is the real story — organic growth has effectively flatlined. Segment data shows Financial Services at $350.2 million and Consumer Goods, Retail & Travel at $273.9 million as the largest verticals, with Software and Hi-Tech at $210.7 million and Emerging Vertical at $235.8 million; the concentration in financial services and consumer/retail, both of which are under AI-driven budget scrutiny, is a structural growth headwind. The investment case now hinges on whether AI-related engineering work can offset the cannibalization of traditional development and testing engagements. Profitability is solid in absolute terms but compressing meaningfully. Q1 2026 net income was $82.5 million on a net margin of 6.92%, down from $109.4 million and a 7.77% net margin in Q4 2025, and well below the $136.3 million and 11.68% net margin posted in Q3 2024. Gross margin has deteriorated from 34.56% in Q3 2024 to 30.07% in Q4 2025 to 25.59% in Q1 2026 — a roughly 900 basis point compression over six quarters that reflects pricing pressure, wage inflation, and a less favorable revenue mix. Operating margin of 9.55% and EBITDA margin of 11.62% in Q1 2026 are respectable for IT services but are clearly trending the wrong way, and the trailing P/E of 30.3x on a 6.92% net margin leaves little cushion if margins compress further. The balance sheet is the strongest part of the story. Debt-to-equity is just 0.039, the current ratio is 2.59, and cash per share is $19.28 against a $117.91 stock price, meaning roughly 16% of the market cap is net cash. However, cash generation has become erratic: TTM free cash flow is $543.6 million, but Q1 2026 free cash flow was negative $54.2 million with operating cash flow of negative $36.4 million, driven by a $229.6 million working capital drain and $32.4 million of stock repurchases. ROE of 10.27% and ROA of 8.45% are healthy but declining from prior-year levels, and the negative quarterly FCF is a yellow flag — the company can fund itself internally given its cash pile, but the deterioration in cash conversion (free cash flow per share of -$1.01 in Q1 2026 versus +$4.88 in Q4 2025) warrants close monitoring.
Quarterly Revenue
$1.4B
2026-03
Revenue YoY Growth
+7.6%
YoY Comparison
Gross Margin
25.6%
Latest Quarter
Free Cash Flow
$543641000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EPAM Overvalued?
Because EPAM is profitable (Q1 2026 net income of $82.5 million), the P/E ratio is the appropriate primary metric. The trailing P/E is 30.3x while the forward P/E is just 8.39x — an extraordinarily wide gap that implies the market expects earnings to roughly triple or quadruple. That forward multiple is based on consensus estimated EPS of $15.17 versus trailing EPS of $0.033, a discrepancy that likely reflects a data artifact in the trailing EPS figure rather than a genuine earnings collapse; nonetheless, the forward P/E of 8.39x is remarkably cheap for a technology services company and suggests the market is pricing in severe skepticism about the sustainability of earnings. The PEG ratio of -2.05 is negative and therefore not meaningful given the earnings distortion. On peer comparison, EPAM's PS ratio of 2.10x and EV/Sales of 0.94x are strikingly low for an IT services firm with 26.5% gross margins and a net cash balance sheet. The P/B ratio of 3.11x and P/CF of 17.48x are moderate. Against a sector where quality IT services names typically trade at 3-5x sales and 20-30x earnings, EPAM's 2.10x sales and 8.39x forward earnings represent a substantial discount — roughly a 40-50% discount to a typical peer multiple on sales and a 60%+ discount on forward earnings. That discount is at least partially justified by the decelerating growth (7.56% YoY), margin compression (gross margin down to 25.59%), and the unresolved AI-disruption question, but it also means expectations are already very low. Historically, EPAM has traded at a premium: the PS ratio was 14.84x in Q4 2023, 10.64x in Q4 2024, and 7.36x in Q1 2025, versus 2.10x today. The P/E has compressed from 43.99x in Q4 2023 and 32.12x in Q4 2024 to 30.31x now, while the P/B has fallen from 4.95x in Q4 2023 to 3.11x. The stock is trading near the bottom of its own multi-year valuation band on every metric — PS is at roughly 14% of its Q4 2023 level. This extreme compression means the market is pricing in either a permanent impairment of the business model or a deep cyclical trough; if EPAM can stabilize growth and margins, the re-rating potential is substantial, but the historical-low multiple also correctly reflects genuine fundamental deterioration.
PE
30.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 20x~70x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. Gross margin has compressed from 34.56% in Q3 2024 to 25.59% in Q1 2026, a roughly 900 basis point decline that directly threatens earnings power. Q1 2026 free cash flow was negative $54.2 million with operating cash flow of negative $36.4 million, driven by a $229.6 million working capital drain, and free cash flow per share swung from +$4.88 in Q4 2025 to -$1.01. Revenue growth has decelerated to 7.56% YoY with a sequential decline from Q4 2025 to Q1 2026, and the company's largest verticals—Financial Services at $350.2 million and Consumer Goods, Retail & Travel at $273.9 million—are under AI-driven budget scrutiny. While the balance sheet is strong with debt-to-equity of 0.039 and cash per share of $19.28, the negative quarterly FCF and declining ROE (10.27%) warrant close monitoring.
Market and competitive risks are elevated. EPAM trades at a forward P/E of 8.39x and PS of 2.10x, which could compress further if growth remains stagnant or if peers re-rate lower. The stock has a beta of 1.383, meaning it is roughly 38% more volatile than the market, and it has underperformed the S&P 500 by 41.52 percentage points over the past year. The AI disruption narrative is a direct competitive threat: if generative AI cannibalizes traditional software development and testing work faster than EPAM can build AI-related engineering revenue, the business model could face permanent impairment. Recent analyst downgrades from Jefferies (May 29, 2026) and Goldman Sachs (May 8, 2026) highlight growing skepticism, and the wide target range ($94 to $200) signals low conviction.
Worst-case scenario: A continued deceleration in organic growth combined with further margin compression could drive the stock back to its 52-week low of $73.06, representing a decline of approximately 38% from the current price of $117.91. The analyst low target of $94.00 implies about 20% downside, but if AI disruption accelerates and Q2 2026 results miss expectations, the stock could break below the June 2026 capitulation low of $76.04 and test the $73.06 level. The maximum drawdown over the past year was -65.65%, demonstrating the severity of prior de-rating. In this adverse scenario, an investor could lose 20% to 38% from current levels, with a retest of the 52-week low being the most realistic downside target.
FAQ
The most severe risk is AI-driven cannibalization of traditional software development and testing work, which could permanently impair the business model. Financial risks include gross margin compression from 34.56% to 25.59% over six quarters and negative Q1 2026 free cash flow of -$54.2 million. Competitive risks include losing market share to AI-native engineering firms and pricing pressure from larger competitors. Macro risks include a beta of 1.383, making the stock 38% more volatile than the market, and sensitivity to IT spending cycles. Company-specific risks include revenue concentration in Financial Services ($350.2M) and Consumer Goods/Retail ($273.9M), both under AI-driven budget scrutiny. Ranked by severity: AI disruption, margin compression, negative cash flow, and competitive threats.
Our 12-month forecast has three scenarios: a base case (50% probability) with a target range of $110-$135, assuming revenue growth stabilizes at 5-8% and gross margin bottoms near 25-27%; a bull case (25% probability) with a target range of $160-$200, assuming successful AI monetization and margin recovery; and a bear case (25% probability) with a target range of $73-$94, assuming accelerating AI disruption and negative revenue growth. The base case is most likely, hinging on Q2 2026 results showing sequential revenue growth and gross margin stabilization. The analyst average target of $122.82 aligns with our base case, while the high target of $200 reflects bull-case optimism and the low target of $94 reflects bear-case pessimism.
EPAM appears undervalued relative to its own history but fairly valued given current fundamentals. The PS ratio of 2.10x is roughly 14% of its Q4 2023 level of 14.84x, and the forward P/E of 8.39x is a 60%+ discount to typical IT services peers at 20-30x. However, the trailing P/E of 30.3x is elevated due to distorted trailing EPS, and the PEG ratio is negative, making it not meaningful. The market is pricing in a permanent impairment of the business model or a deep cyclical trough. If EPAM can stabilize growth and margins, the re-rating potential is substantial, but the historical-low multiple correctly reflects genuine fundamental deterioration.
EPAM is a high-risk, high-reward proposition that is not suitable for all investors. The stock trades at 8.39x forward earnings and 2.10x sales, which is extremely cheap relative to its historical multiples and IT services peers, but this discount reflects real concerns about AI-driven disruption and margin compression. Analyst consensus is 'buy' with an average target of $122.82, implying only 4.2% upside, though the high target of $200 suggests 70% upside if growth recovers. The biggest downside risk is a retest of the 52-week low of $73.06, representing 38% downside. For risk-tolerant investors with a long time horizon, the risk/reward is favorable if Q2 2026 shows stabilizing growth and margins; for others, waiting for clearer evidence is prudent.
EPAM is better suited for long-term investors with a minimum holding period of 2-3 years, given the deep-value nature of the opportunity and the need for the AI disruption narrative to resolve. The stock's beta of 1.383 and maximum drawdown of -65.65% make it too volatile for short-term trading unless using tight risk management. The company pays no dividend (payout ratio of 0), so returns depend entirely on capital appreciation. Earnings visibility is currently low due to the AI transition, but the strong balance sheet (debt-to-equity of 0.039, cash per share of $19.28) provides a margin of safety. Short-term traders could exploit the recent momentum (up 17.57% in one month) but face high risk of reversal. A long-term horizon allows time for the AI strategy to prove out and for multiples to re-rate.
